Effects of over-expression of ANXA10 gene on proliferation and apoptosis of hepatocellular carcinoma cell line HepG2

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 32, Issue 5, 2012, Pages 669-674

  Liu, Xiaohui ^a   Peng, Xiaodong ^b   Hu, Zhenzhen ^b   Zhao, Qingmei ^b   He, Jian ^b   Li, Junhe ^b   Zhong, Xiaojun ^b  

^a GANNAN MEDICAL UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

ANXA10; Cell apoptosis; Cell proliferation; Hepatocellular carcinoma; Lentiviral vector; Overexpression

Indexed keywords

ANNEXIN; ANXA10 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; GENETICS; HEPG2 CELL LINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; TUMOR CELL LINE;

ANNEXINS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS;

EID: 84870563571     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-012-1015-5     Document Type: Article

References (20)

1. Parkin D, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005, 55(2):74-108 (Pubitemid 40372904)
2. Yang BH, Zhang BH, Xu Y, et al. Prospective study of early detection for primary live cancer. J Cancer Res Clin Oncol, 1997, 123(2):357-360 (Pubitemid 27286510)
3. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin, 2002, 52(1):23-47 (Pubitemid 34110469)
4. Llovet JM, Burroughs A, Bruix J, et al. Hepatocellular carcinoma. Lancet, 2003, 362:1907-1917 (Pubitemid 37518510)
5. Morgan RO, Jenkins NA, Gilbert DJ, et al. Novel human and mouse annexin A10 are linked to the genome duplications during early chordate evolution. Genomics, 1999, 60(1):40-49 (Pubitemid 29422812)
6. Liu SH, Lin CY, Peng SY, et al. Down-regulation of annexinA10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. Am J Pathol, 2002, 160(5): 1831-1837
7. Kim B, Bang S, Lee S, et al. Expression profiling and subtype-specific expression of stomach cancer. Cancer Res, 2003, 63(23):8248-8255 (Pubitemid 37549475)
8. Van Baal JW, Milana F, Rygiel AM, et al. A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma. Cell Oncol, 2008, 30(1):63-75 (Pubitemid 351161034)
9. Prasad NB, Biankin AV, Fukushima N, et al. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res, 2005, 65(5):1619-1626 (Pubitemid 40478583)
10. Van Baal JW, Milano F, Rygiel AM, et al. A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia. Gastroenterology, 2005, 129(4):1274-1281 (Pubitemid 41446866)
11. Mo P, Shi RH, Zhang HJ, et al. Detection of annexin A10 in human esophageal squamous cancer tissues. Acta Univ Med Nanjing (Natural Science) (Chinese), 2008, 28(5): 658-660
12. Peng SY, Ou YH, Chen WJ, et al. Aberrant expressions of annexin A10 short isoform, osteopontin and alpha- fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma. Int J Oncol, 2005;26(2):1053-1061.
13. Kim J, Kim MA, Jee CD, et al. Reduced expression and homozygous deletion of annexinA10 in gastric carcinoma. Int J Cancer, 2009, 125(8):1842-1850.
14. Peng SY, Pan HW. Synergistic effects of aberrant expression of alpha-fetoprotein, annexin A10 and osteopontin at chromosome 4q in the tumor progression, early recurrence and poor prognosis of hepatocellular carcinoma. Int J Oncol, 2005, 26(4):1053-1061
15. Peng XD, Xiao GW, Liu XH, et al. Relationship of annexin A10 with matrix metalloproteinases-9, vascular endothelial growth factor expressed in human hepatocellular carcinoma and their relationship with clinicopathological features. Chin J Exp Surg (Chinese), 2010, 27 (12):1844 -1846
16. Rubinson DA, Dillon CP, Kwiatkowski AV, et al. A lentivirus- based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet, 2003, 33(3):401-406 (Pubitemid 36278858)
17. Lu X, Humeau L, Slepushkin V, et al. Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one step protocol. J Gene Med, 2004, 6(9):963-973 (Pubitemid 40228111)
18. Kappes JC, Wu X, Wakefield JK, et al. Production of trans-lentiviral vector with predictable safety. Methods Mol Med, 2003, 76(13):449-465
19. Strang BL, Ikeda Y, Cosset FL, et al. Characterization of HIV-l vectors with gamma retrovirus envelope glycoproteins produced from stable packaging cells. Gene Therapy, 2004, 11(7):591-598 (Pubitemid 38455977)
20. Suter SE, Gouthro TA, McSweeney RA, et al. Optimized transduction of canine paediatric CD34+ cells using an MSCV-based bicistronic vector. Vet Res Commun, 2006, 30(8):881-901 (Pubitemid 46195455)